- Filed
- Feb 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 5, 2025 | 13.87M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $26.04M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $27.4M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $2M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $2.16M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $2.82M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $2.96M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $39.97M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $40.32M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $48.37M |
| Stockholders Equity restated | Q2 2025 · Dec 31, 2023 | $50.72M |
| Stockholders Equity restated | Q2 2025 · Sep 30, 2023 | $50.53M |
| Stockholders Equity restated | Q2 2025 · Jun 30, 2023 | $52.02M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $51.96M |
| Total Assets | Q2 2025 · Dec 31, 2023 | $53.63M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 14.29M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 14.38M sh |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $1.17M |
| Dividends Paid | Q2 2025 · Dec 31, 2023 | $648K |
| Capex | Q2 2025 · Dec 31, 2023 | $111K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $910K |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.09 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.07 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.09 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.07 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $1.49M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $2.99M |
| Net Income | Q2 2025 · Dec 31, 2023 | $1.23M |
| Net Income | Q2 2025 · Dec 31, 2023 | $1.05M |
| Net Income | Q2 2025 · Sep 30, 2023 | −$176K |
| Operating Income | Q2 2025 · Dec 31, 2023 | $192K |
| Operating Income | Q2 2025 · Dec 31, 2023 | $406K |